Review
Prostate Cancer and Prostatic Diseases (2005) 8, 127–132. doi:10.1038/sj.pcan.4500779 Published online 11 January 2005
Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade
W A Woodward1, P Wachsberger2, R Burd2 and A P Dicker2
- 1Department of Radiation Oncology, UTMD Anderson Cancer Center, Houston, TX, USA
- 2Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Kimmel Cancer Center, Philadelphia, Pennsylvania, USA
Correspondence: AP Dicker, Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Kimmel Cancer Center, 111 South 11th St, Philadelphia, PA 19107-5097, USA. E-mail: adam.dicker@mail.tju.edu
Received 21 June 2004; Revised 15 October 2004; Accepted 3 November 2004; Published online 11 January 2005.
Abstract
Antiandrogen therapy is an important modality in the treatment of prostate cancer. Recent research into the role of angiogenesis in tumour growth and metastasis has uncovered links between antiandrogen therapy, radiation therapy and angiogenesis, which have exciting implications for the treatment of prostate cancer. Angiogenic cytokines such as vascular endothelial growth factor (VEGF) have been identified in prostate cancer cells and tumours, and androgens appear to stimulate VEGF. This article assesses the antiangiogenic effects of hormonal therapy and assesses the role that angiogenesis may play in the observed cooperation between hormonal and radiation therapies for prostate cancer.
Keywords:
prostate cancer, hormonal therapy, radiation therapy, angiogenesis, VEGF
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Cancer Blood vessels kept quiet
Nature News and Views (05 Mar 2009)
Chemotherapeutic drugs?more really is not better
Nature Medicine News and Views (01 May 2000)
RESEARCH
Journal of Cerebral Blood Flow & Metabolism Original Article
Journal of Cerebral Blood Flow & Metabolism Original Article
